Getting to know us

Our team brings decades of successful experience in investing, innovating, and operating across sectors - having executed multi billion in transactions, covering the full investment lifecyle and capital stack. and led companies across numerous countries

Differentiated Culture
Diffentiated Expertise

We bring together a unique blend of world-leading doctors and scientists, seasoned entrepreneurs, and experienced investors with decades of expertise at the forefront of Medicine, Technology, and Investment. Our scientific advisors are internationally recognized experts in Neuroscience and Surgery, Biomedical Engineering, Healthcare Technologies, Clinical Trial Optimization, AI, and Data Science

Our values-driven culture is built on Genuine Partnership and Deep Curiosity, fostering an intellectually vibrant environment of collaboration, disciplined execution, and critical analysis. We are deeply committed to Integrity and Humility, ensuring that every engagement - with scientific innovators, management teams, investors, and communities - is guided by trust, transparency, and a shared vision for sustainable value creation.

Our team

Aris Kekedjan

Experienced global multi-industry business builder, former Chief Investment Officer at General Electric (NYSE: GE), former Chair & CEO at Trinity Biotech (NASDAQ: TRIB) and CEO at Carl Icahn Enterprises (NASDAQ: IEP). Current Board Member at Stratasys, and former Board Member at XPO Logistics, XEROX and FinServ Acquisition Corp.

Donald Ewer

Experienced Private Investor and Portfolio Manager in global top-tier Hedge Funds, including Citadel, Caxton, Segantii, managing institutional investment portfolios primarily investing in Credit and Special situations. He was ranked in the top 5 investors in Asia by the Asset journal for credit - circa 8 years running. Currently Board member at VX Pharma, Etcembly and Evolvere Biosciences.

Julien Nicod

Experienced Entrepreneur, Investor, Advisor  in Healthcare and Life Sciences, Deep Technology, and Industrials. Founded the ALTs ecosystem. inclduing ALTs Club, a specialist membership-based research and advisory firm purpose-built for sophisticated LP investors. Previously advised a range of investment firms, including Top-tier Private Equity firms and Single Family ofices. 

Venture Partners

Dr Elad Levy

Elad I. Levy is Professor of Neurosurgery and Radiology and Chair of Neurological Surgery at the Jacobs School of Medicine, SUNY Buffalo. He has co-authored over 500 peer-reviewed publications, served on the CNS Executive Committee since 2007, and is a past president of the CNS Foundation, where he helped launch global philanthropic initiatives. He currently serves as Vice Chair of the American Board of Neurological Surgery and Endovascular Section Editor for Neurosurgery. Dr. Levy is internationally recognized for his leadership in advancing neurovascular care, education, and innovation.

Dr Aimee de Gaetano

Aimee de Gaetano is a leading expert in neurological innovation, clinical strategy, and global medical affairs, with a background spanning clinical research, digital health, and technology development. She has authored over 500 abstracts and clinical manuscripts and has led multi-institutional initiatives focused on patient-centered care and translational research. Aimee has also served in advisory roles across academia, industry, and nonprofit sectors, shaping global strategies in neurology and neurotechnology.

Dr Vadim Pinskiy


Dr. Vadim Pinskiy is a neuroscientist and technology leader with deep expertise in biomedical engineering, data science, and translational research. He has led cross-functional teams in the development of advanced imaging technologies, data platforms, and AI-driven tools for neuroscience. Dr. Pinskiy has published extensively in the fields of neuroimaging and computational biology and has overseen large-scale research programs spanning academia and industry.